Trials Save Lives
TODAY, TOMORROW, FOREVER
We are a group of world-leading doctors and researchers based in Australia and New Zealand, who are committed to finding new treatments and prevention strategies for every person diagnosed with breast cancer through clinical trials research.
Since our inception in 1978, we have conducted a multi-centre clinical trials research program which brings together a unique collaboration of researchers, trial participants and supporters.
Together, we have improved the treatment of breast cancer, changed the way breast cancer is managed and saved the lives of millions of people, through international research collaboration.
926
RESEARCHERS
There are 926 researchers, including oncologists, surgeons, pathologists, radiologists and nurses, who are involved in the conduct of the BCT research program.
114
INSTITUTIONS
Our research program brings together 114 institutions in Australia and New Zealand, as well as 65 sites in Chile, Spain, Switzerland and Taiwan.
17,169
TRIAL PARTICIPANTS
Since 1978, 17,169 people have participated in our clinical trials, to help us find new and better treatments for breast cancer.
93
CLINICAL TRIALS
Our research program encompasses approximately 93 clinical trials in various stages of recruitment, follow-up, analysis and publication.
1,277
PUBLICATIONS
We have contributed to 1,277 scientific publications, which are advancing medical knowledge and improving treatments and prevention strategies for breast cancer.
22,000
SUPPORTERS
Our research is made possible thanks to the generosity of individuals, businesses, trust and foundations, organisations and community groups who donated and raised funds in 2022-2023.
ABOUT BREAST CANCER TRIALS
Breast Cancer Trials is grounded and defined by one simple belief: We can and we will find new and better treatments and prevention strategies for every person affected by breast cancer that saves lives today, tomorrow and forever.
OUR RESEARCH
During the reporting period we launched our 2022-2026 Research Strategy, which identifies key priority areas of research that are likely to make the greatest impact to people affected by breast cancer.
RESEARCH RESULTS
A number of new publications in the reporting period, which answered important scientific questions, are expected to translate into improved outcomes for women.
OVERVIEW
ASSESSING THE EFFECT OF BREAST CANCER TREATMENT ON OVARIAN FUNCTION
BLOCKING CELL DIVISION HELPS WITH BREAST CANCER RELAPSE IN OLDER WOMEN
BREAST MRI MAY ALLOW SOME PATIENTS TO SAFELY AVOID RADIATION THERAPY
NEW OPTIONS FOR TRIPLE NEGATIVE BREAST CANCER PATIENTS
OLAPARIB INCREASES SURVIVAL FOR EARLY BREAST CANCER PATIENTS WITH BRCA1-2 GENE MUTATIONS
REPURPOSING A COMMON REFLUX DRUG TO EASE CHEMOTHERAPY NAUSEA
SUPPRESSING OVARIAN FUNCTION INCREASES BREAST CANCER SURVIVAL IN HIGH-RISK PREMENOPAUSAL WOMEN
TREATMENT SIMPLIFIED - NO NEED TO START HORMONAL THERAPY ALONGSIDE CHEMOTHERAPY
OUR PEOPLE
Breast Cancer Trials is governed by a Board of Directors and the terms of its Constitution.
OUR SUPPORTERS
Financial support for Breast Cancer Trials is critical to ensuring better treatments, prevention and a future filled with hope.
FINANCIALS
Each year, Breast Cancer Trials undergoes an independent financial audit to ensure its compliance with all applicable company, taxation, charitable and financial legislation and regulation.
HOW YOU CAN HELP
There are many ways you can connect with Breast Cancer Trials and show your support.